Reducing expression of NAD<sup>+</sup> synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration
Laura Conforti(University of Cincinnati), Michael P. Coleman(Babraham Institute), Giuseppe Orsomando(Marche Polytechnic University), Lucie Janečková(Institute of Molecular Genetics), M. Di Stefano(Università Cattolica del Sacro Cuore), Caterina Bendotti(Mario Negri Institute for Pharmacological Research), Neil Smyth(Southampton General Hospital), Diana Wagner(Christian-Albrechts-Universität zu Kiel), Francesca Mazzola(Marche Polytechnic University), Lucia Cialabrini(Marche Polytechnic University), Giulio Magni(Marche Polytechnic University)
Cited by 77
Related Papers
Wallerian degeneration: an emerging axon death pathway linking injury and disease
|Nature reviews. Neuroscience|2014|627
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene
|Nature Neuroscience|2001|616
A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration
|Cell Death and Differentiation|2014|263
A <i>Ufd2/D4Cole1e</i> chimeric protein and overexpression of <i>Rbp7</i> in the slow Wallerian degeneration ( <i>Wld</i> <sup>S</sup> ) mouse
|Proceedings of the National Academy of Sciences|2000|253